Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 6243
TargetSodium/glucose cotransporter 2(Human)
Pfizer

US Patent
LigandPNGBDBM119375(US8669380, 1)
Affinity DataIC50: 2.60nMAssay Description:The SGLT2 functional assay was designed to detect the inhibition of methyl-alpha-D glucopyranoside (AMG a non-metabolizable form of glucose) uptake v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Pfizer

US Patent
LigandPNGBDBM119379(US8669380, 8)
Affinity DataIC50: 3nMAssay Description:The SGLT2 functional assay was designed to detect the inhibition of methyl-alpha-D glucopyranoside (AMG a non-metabolizable form of glucose) uptake v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Pfizer

US Patent
LigandPNGBDBM119379(US8669380, 8)
Affinity DataIC50: 4nMAssay Description:The SGLT2 functional assay was designed to detect the inhibition of methyl-alpha-D glucopyranoside (AMG a non-metabolizable form of glucose) uptake v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Pfizer

US Patent
LigandPNGBDBM119377(US8669380, 3)
Affinity DataIC50: 5nMAssay Description:The SGLT2 functional assay was designed to detect the inhibition of methyl-alpha-D glucopyranoside (AMG a non-metabolizable form of glucose) uptake v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Pfizer

US Patent
LigandPNGBDBM119377(US8669380, 3)
Affinity DataIC50: 6.70nMAssay Description:The SGLT2 functional assay was designed to detect the inhibition of methyl-alpha-D glucopyranoside (AMG a non-metabolizable form of glucose) uptake v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Pfizer

US Patent
LigandPNGBDBM119378(US8669380, 4)
Affinity DataIC50: 45.9nMAssay Description:The SGLT2 functional assay was designed to detect the inhibition of methyl-alpha-D glucopyranoside (AMG a non-metabolizable form of glucose) uptake v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Pfizer

US Patent
LigandPNGBDBM119376(US8669380, 2)
Affinity DataIC50: 1.09E+3nMAssay Description:The SGLT2 functional assay was designed to detect the inhibition of methyl-alpha-D glucopyranoside (AMG a non-metabolizable form of glucose) uptake v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Pfizer

US Patent
LigandPNGBDBM119376(US8669380, 2)
Affinity DataIC50: 1.77E+3nMAssay Description:The SGLT2 functional assay was designed to detect the inhibition of methyl-alpha-D glucopyranoside (AMG a non-metabolizable form of glucose) uptake v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2014
Entry Details
Go to US Patent